A detailed history of Ransom Advisory, LTD transactions in Organon & Co. stock. As of the latest transaction made, Ransom Advisory, LTD holds 46 shares of OGN stock, worth $346. This represents 0.0% of its overall portfolio holdings.

Number of Shares
46
Previous 2,146 97.86%
Holding current value
$346
Previous $22.9 Million 100.0%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026

SELL
$6.34 - $11.01 $13,314 - $23,121
-2,100 Reduced 97.86%
46 $0
Q3 2025

Oct 07, 2025

BUY
$8.4 - $10.85 $18,026 - $23,284
2,146 New
2,146 $22.9 Million
Q3 2025

Oct 03, 2025

SELL
$8.4 - $10.85 $18,026 - $23,284
-2,146 Closed
0 $22.9 Million
Q2 2025

Jul 08, 2025

SELL
$8.04 - $14.72 $160 - $294
-20 Reduced 0.92%
2,146 $20.8 Million
Q1 2025

May 20, 2025

BUY
$14.29 - $16.41 $30,952 - $35,544
2,166 New
2,166 $32.3 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $1.92B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ransom Advisory, LTD Portfolio

Follow Ransom Advisory, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ransom Advisory, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ransom Advisory, LTD with notifications on news.